While PPSV23 is generally recommended for individuals aged 65 and older, it is also strongly advised for people with various underlying health conditions, including cancer. According to the Centers for Disease Control and Prevention (CDC), cancer patients—particularly those undergoing treatments like chemotherapy—should discuss with their healthcare providers about the best time to receive the vaccine.
